Medical Marijuana: Obama Administration Continues Reefer Madness

Medical Marijuana: Obama Administration Continues Reefer Madness

Filed under: drug abuse treatment outcome study

According to ASA, no large bank in Colorado will service legal medical marijuana businesses;; The National Institute on Drug Abuse (NIDA) has begun obstructing research by denying marijuana to scientists. Thus, Sue Sisley, MD, a psychiatrist and …
Read more on Truth-Out

 

Letter: NCYSAP Reminds Residents of Dangers of Youth Marijuana Use

Filed under: drug abuse treatment outcome study

The Needham Coalition for Youth Substance Abuse Prevention, or NCYSAP, a community coalition dedicated to reducing youth substance use and supporting youth in healthy decision making, is continuing our work to provide educational, science based …
Read more on Patch.com

 

Bioniche Life Sciences Inc. Announces Discontinuation of Current Phase III

Filed under: drug abuse treatment outcome study

The trial, a randomized, active-controlled, open-label, multi-center study with a blinded endpoint assessment designed to compare UrocidinTM with mitomycin C in the intravesical treatment of patients with BCG recurrent or refractory non-muscle-invasive …
Read more on Sacramento Bee

 

Novelos Therapeutics Closes Million Private Placement

Filed under: drug abuse treatment outcome study

5, 2012 — /PRNewswire/ — Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced the closing of a private placement of equity securities to an affiliated …
Read more on Sacramento Bee

 


 

CTN Webinar: Relapse Prevention. – This 90-minute webinar, produced by the National Drug Abuse Treatment Clinical Trials Network (CTN) Clinical Coordinating Center for CTN members and the public, explores the issue of relapse among individuals with substance use disorders (SUD). Outcome studies, types and effects of lapse and relapse, and factors contributing to relapse are reviewed. A major emphasis of the webinar is on discussing specific clinical strategies to reduce relapse risk, with a focus on current empirical and clinical literature, including findings from quality improvement studies and clinical trials conducted in a drug treatment clinic. The target audience is CTN members and other researchers and clinicians interested in learning more about relapse prevention. Presented by Dennis Daley, PhD, LSW (Western Psychiatric Institute and Clinic, AT Node) and Dennis M. Donovan, PhD (Alcohol & Drug Abuse Institute, University of Washington, PN Node). For more resources related to this webinar, as well as other webinars in this series, visit: ctndisseminationlibrary.org